Purple Biotech PPBT
NASDAQ PPBT
$1.52 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Cash from Financing Activities (2014 - 2026)

Updated

Purple Biotech (PPBT) recorded Cash from Financing Activities of $2.12 million in Q2 2026, up 478.7% from $366,000 a year earlier.

Analysis

Purple Biotech (PPBT) Cash from Financing Activities (2014 - 2026) Analysis & Trends

On a TTM basis, Purple Biotech's Cash from Financing Activities came in at $7.92 million as of Jun 30, 2026, up 21.0% year-over-year; for FY2025, it came in at $6.33 million, down 6.5% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -37.9% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $6.77 million in FY2024 (+24.3%), $5.45 million in FY2023 (+389.1%), $1.11 million in FY2022 (-26.3%) and $1.51 million in FY2021 (-97.8%).
  • Quarterly Cash from Financing Activities has ranged from -$64,000 in Q1 2026 to $5.57 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Cash from Financing Activities rose in three of the last seven quarters, with growth averaging 105.1%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 478.7% in Q2 2026, against a decline of 92.5% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$64,000 (Q1 2026), $297,000 (Q4 2025) and $5.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Purple Biotech 249,214.64 191,214.64 - 2.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.12 Mn
Mar 31, 2026 -64,000.00
Dec 31, 2025 297,000.00
Sep 30, 2025 5.57 Mn
Jun 30, 2025 366,000.00
Mar 31, 2025 103,000.00
Dec 31, 2024 3.94 Mn
Sep 30, 2024 2.13 Mn
Jun 30, 2024 433,000.00
Mar 31, 2024 268,000.00
Dec 31, 2023 4.25 Mn
Sep 30, 2023 572,000.00
Jun 30, 2023 367,000.00
Mar 31, 2023 264,000.00
Dec 31, 2022 89,000.00
Sep 30, 2022 569,000.00
Jun 30, 2022 294,000.00
Mar 31, 2022 162,000.00
Dec 31, 2021 479,000.00
Sep 30, 2021 -57,000.00
API Access

Purple Biotech Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PPBT&period=max&api_key=YOUR_API_KEY